Suppr超能文献

急性发作期精神分裂症患者精神病性发作的严重程度对同时存在的抑郁和焦虑症状的预测作用

Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.

作者信息

Naidu Kalai, van Staden Werdie C W, van der Linde Mike

机构信息

Department of Psychiatry, University of Pretoria, Private Bag X323, Arcadia, Pretoria 0007, South Africa.

出版信息

BMC Psychiatry. 2014 Jun 5;14:166. doi: 10.1186/1471-244X-14-166.

Abstract

BACKGROUND

Considering that depressive and anxiety symptoms are common in schizophrenia, this study investigated whether the severity of a psychotic episode in an acute phase schizophrenia cohort is predictive of concurrent depressive and anxiety features.

METHOD

Fifty one recently hospitalised patients suffering from acute phase schizophrenia participated prospectively in a cross-sectional study. The severity of the psychotic episode, the depressive features and the anxiety features were measured by the Structured Clinical Interview for Positive and Negative Syndrome Scale (SCI-PANSS), the Calgary Depression Scale for Schizophrenia (CDSS), the Hamilton Anxiety Rating Scale (HAM-A) and the Staden Schizophrenia Anxiety Rating Scale (S-SARS). The total SCI-PANSS-scores were adjusted to exclude appropriately the depression or anxiety items contained therein. To examine akathisia as potential confounder, the Barnes Akathisia Scale was also applied. The relationships were examined using linear regressions and paired t-tests were performed between lower and higher scores on the SCI-PANSS.

RESULTS

A higher adjusted total SCI-PANSS-score predicted statistically significantly higher scores for depressive features on the CDSS (p < 0.0001) and for anxiety features on the HAM-A (p = 0.05) and the S-SARS (p < 0.0001). The group that scored more or equal to the median (=99) of the adjusted total SCI-PANSS, scored significantly higher (p < 0.0001) on the CDSS, the HAM-A and the S-SARS than the group scoring below it. Akathisia measured distinctly different (p < 0.0001) from both the anxiety measures.

CONCLUSION

The study suggests that the severity of a psychotic episode in acute phase schizophrenia predicts the severity of concurrent depressive and anxiety features respectively.

摘要

背景

鉴于抑郁和焦虑症状在精神分裂症中很常见,本研究调查了急性期精神分裂症队列中精神病性发作的严重程度是否可预测同时存在的抑郁和焦虑特征。

方法

51名近期住院的急性期精神分裂症患者前瞻性地参与了一项横断面研究。通过阳性和阴性症状结构临床访谈量表(SCI-PANSS)、卡尔加里精神分裂症抑郁量表(CDSS)、汉密尔顿焦虑评定量表(HAM-A)和斯塔登精神分裂症焦虑评定量表(S-SARS)来测量精神病性发作的严重程度、抑郁特征和焦虑特征。对SCI-PANSS总分进行调整,以适当排除其中包含的抑郁或焦虑项目。为了检验静坐不能作为潜在混杂因素,还应用了巴恩斯静坐不能量表。使用线性回归检验相关性,并在SCI-PANSS的低分和高分之间进行配对t检验。

结果

调整后的SCI-PANSS总分较高在统计学上显著预测了CDSS上抑郁特征得分较高(p < 0.0001)以及HAM-A(p = 0.05)和S-SARS(p < 0.0001)上焦虑特征得分较高。调整后的SCI-PANSS总分得分大于或等于中位数(=99)的组在CDSS、HAM-A和S-SARS上的得分显著高于得分低于中位数的组(p < 0.0001)。静坐不能与两种焦虑测量的差异均极为显著(p < 0.0001)。

结论

该研究表明,急性期精神分裂症中精神病性发作的严重程度分别预测了同时存在的抑郁和焦虑特征的严重程度。

相似文献

2
Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
J Clin Psychiatry. 1999 Nov;60(11):747-51. doi: 10.4088/jcp.v60n1105.
3
Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
Compr Psychiatry. 2012 Feb;53(2):145-51. doi: 10.1016/j.comppsych.2011.03.009. Epub 2011 May 31.
4
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
J Affect Disord. 2000 May;58(2):107-15. doi: 10.1016/s0165-0327(99)00075-0.
5
Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period.
Schizophr Res. 2001 Mar 1;47(2-3):135-40. doi: 10.1016/s0920-9964(00)00002-5.
6
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
8
[Influence of resistance to voices on depression].
Encephale. 2015 Feb;41(1):25-31. doi: 10.1016/j.encep.2014.01.006. Epub 2014 May 9.

引用本文的文献

1
Arabic translation and validation of the clinician administered Staden schizophrenia anxiety rating scale (S-SARS).
Heliyon. 2024 Oct 23;10(21):e39792. doi: 10.1016/j.heliyon.2024.e39792. eCollection 2024 Nov 15.
2
The Impact of Baseline Anxiety on Drug Placebo Separation and Drug/Placebo Response in an Acute Schizophrenia Clinical Trial-A Post-hoc Analysis.
Schizophr Bull Open. 2023 Jan 28;4(1):sgad003. doi: 10.1093/schizbullopen/sgad003. eCollection 2023 Jan.
4
Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale.
Front Psychiatry. 2022 Sep 20;13:992745. doi: 10.3389/fpsyt.2022.992745. eCollection 2022.
5
Validity and Reliability of the Staden Schizophrenia Anxiety Rating Scale.
Diagnostics (Basel). 2022 Mar 28;12(4):831. doi: 10.3390/diagnostics12040831.
7
Discerning undifferentiated anxiety from syndromal anxiety in acute-phase schizophrenia.
Ann Gen Psychiatry. 2020 Apr 15;19:26. doi: 10.1186/s12991-020-00277-4. eCollection 2020.
9
The Difference between Hospital Anxiety and Depression Scale - Anxiety Scores in Batak Male and Female with Schizophrenia: Preliminary Study.
Open Access Maced J Med Sci. 2019 Aug 29;7(16):2599-2601. doi: 10.3889/oamjms.2019.401. eCollection 2019 Aug 30.
10
Anxiety in Patients with Schizophrenia: Epidemiology and Management.
CNS Drugs. 2015;29(10):819-32. doi: 10.1007/s40263-015-0282-7.

本文引用的文献

1
Depression and impulsivity as pathways to violence: implications for antiaggressive treatment.
Schizophr Bull. 2014 Jul;40(4):886-94. doi: 10.1093/schbul/sbt117. Epub 2013 Aug 13.
2
Assessment of trait and state aspects of depression in schizophrenia.
Schizophr Bull. 2014 Jan;40(1):132-42. doi: 10.1093/schbul/sbt069. Epub 2013 May 17.
3
Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
Compr Psychiatry. 2012 Feb;53(2):145-51. doi: 10.1016/j.comppsych.2011.03.009. Epub 2011 May 31.
4
The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study.
Eur Psychiatry. 2012 May;27(4):240-4. doi: 10.1016/j.eurpsy.2010.10.007. Epub 2011 Feb 2.
5
Impact of panic attacks on quality of life among patients with schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1300-5. doi: 10.1016/j.pnpbp.2010.07.014. Epub 2010 Jul 24.
6
How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.
Schizophr Bull. 2011 Jul;37(4):811-21. doi: 10.1093/schbul/sbp148. Epub 2009 Dec 3.
7
Comorbid anxiety in patients with psychosis.
Psychiatr Danub. 2009 Sep;21 Suppl 1:43-50.
8
Co-morbid social phobia in schizophrenia.
Int J Soc Psychiatry. 2009 May;55(3):198-202. doi: 10.1177/0020764008093447.
9
Recent advances in the understanding and treatment of anxiety disorders.
Prim Care. 2007 Sep;34(3):475-504, v-vi. doi: 10.1016/j.pop.2007.05.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验